Sales Center Record Keeping: Supply Chain Record, Adverse Event Notification, Unsafe Device Announcement and ÜTS

SUMMARY
The sales center’s record-keeping obligation is regulated in Article 31 of the Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği (Regulation on Medical Device Sales, Advertising and Promotion): supply chain records are kept for at least ten years from the date the device begins to be made available on the market. For documents relating to activities, Article 8 provides five years.
This article gives the four paragraphs of Article 31, the five-year period in Article 8, Articles 14 and 25 of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation) concerning distributors, and the withdrawal and destruction notifications in the ÜTS Tekil Hareket Bildirimleri Kılavuzu (ÜTS Individual Movement Notifications Guide) as direct quotations.
ÜTS registration and individual notification services for your sales center: Medical Device ÜTS Registration Consultancy
Contents
1. Article 31: Title and Scope
Article 31 bears the title “Piyasa gözetimi ve denetimi, uyarı sistemi, kayıt ve bilgi yönetim sistemi” (Market surveillance and control, alert system, record and information management system) and consists of four paragraphs: adverse event notification, unsafe device announcement, supply chain record and record system. Article 4 of the Regulation defines an adverse event as follows:
“(ı) Adverse event: the technical and medical reasons, related to the characteristics and performance of the device, which lead or may lead to a serious deterioration in the state of health of the patient or user, or to death, through a deterioration or deviation in the characteristics and/or performance of the device or inadequacies in the instructions for use and labelling, or which lead to a systematic recall of devices of the same type from the market by the manufacturer for those reasons,”
2. Adverse Event Notification: Article 31/1
“(1) Sales centers shall immediately notify the Agency and the manufacturer or importer of the device concerned of the adverse events they encounter during their activities relating to their own devices or other devices.”
Scope: their own devices and other devices.
Addressee: the Agency and the manufacturer or importer of the device concerned.
Time limit: immediately.
The obligations of personnel establish the same chain:
“(c) shall immediately forward to the responsible manager the adverse events reported to them concerning the device during sales and promotion.”
“(6) Clinical support staff shall immediately forward to the responsible manager the adverse events reported to them concerning the device.”
“(9) The responsible manager shall immediately notify the Agency and the manufacturer or importer of the device concerned of the adverse events reported concerning the devices sold.”
These provisions are in Articles 11/4-c, 12/6 and 10/9 respectively. For serious adverse event reporting under the Tıbbi Cihaz Yönetmeliği, see our article on vigilance and serious adverse event reporting.
3. Unsafe Device Announcement: Article 31/2
“(2) Sales centers are obliged to immediately stop the sale of devices that are determined to be unsafe or contrary to technical regulation within the scope of market surveillance and control and the alert system and announced by the Agency, to return these devices to their manufacturer or importer, and to share with the Agency, upon request, all kinds of information and documents relating to the firm, the user and the activities carried out on the matter concerning the device sold.”
Stopping the sale immediately.
Returning the devices to the manufacturer or importer.
Sharing with the Agency, upon request, the information and documents on the firm, the user and the activities relating to the device sold.
Acting contrary to this paragraph is a ground for temporary suspension of activity under Article 29:
“(1) In the cases listed below, the activity of the sales center shall be temporarily suspended for fifteen days:”
“(e) (Added: Official Gazette 26/5/2023-32202) Acting contrary to the second paragraph of Article 31.”
If the act is repeated within a year, the activity is suspended for thirty days under the fifth paragraph of Article 29. For all of the sanctions, see our article on sales center inspection and suspension of activity.
4. Ten-Year Supply Chain Record: Article 31/3
“(3) Sales centers shall keep, in an orderly manner and on the basis of parameters such as batch, series, lot, brand and model, the records of the name, trade name or brand and contact details of the previous and, if any, the next economic operator in the supply chain, and other information that will facilitate the tracking of devices; they shall retain these records for at least ten years from the date they begin to make the device available on the market and shall submit them to the Agency upon request.”
Whose record: the previous and, if any, the next economic operator in the supply chain.
Which information: name, trade name or brand, contact details and other information that will facilitate tracking.
Which level: on the basis of parameters such as batch, series, lot, brand and model.
How long: at least ten years from the date the device begins to be made available on the market.
5. Five-Year Activity Documents: Article 8
The fifth and sixth paragraphs of Article 8 impose a separate retention obligation:
“(5) The sales center keeps records on the infrastructure, personnel and devices relating to its activities and complies with the Agency’s record and information management system.”
“(6) The sales center retains the documents relating to the activities it has carried out under this Regulation for five years and presents them upon the request of the Agency or the Directorate.”
For supply chain records the period is at least ten years under Article 31/3, and for activity documents five years under Article 8/6. The responsible manager’s obligation during inspection is in the fourth paragraph of Article 27:
“(4) The responsible manager of the sales center is obliged to provide every facility during these inspections and to hand over all information, documents and books requested.”
6. ÜTS Registration and Responsibility for Accuracy: Article 31/4
“(4) (Amended: Official Gazette 26/5/2023-32202) The Agency issues guides on the registration of devices in the record and information management system. Sales centers establish the infrastructure in accordance with these guides within the specified periods and register the devices in the system. The accuracy of the information on the devices registered in the system is the responsibility of the sales center that makes the product registration.”
Article 28/A on false records:
“(1) If the Agency determines that applications have been made to the record and information management systems with false information and documents, it may restrict the access of the persons or organizations making these transactions to the relevant record and information management systems.”
“(2) If it is determined that repeated transactions have been made in the Agency’s record and information management systems contrary to the procedures and principles determined by the Agency, the trainings received by the persons making these transactions under the tenth paragraph of Article 26 of this Regulation shall be cancelled.”
7. Tıbbi Cihaz Yönetmeliği (Medical Device Regulation): Distributor’s Record and Notification Obligations
Article 4 of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation) defines the distributor as follows:
“(j) Distributor: any natural or legal person in the supply chain, other than the manufacturer or the importer, that makes a device available on the market up to the point of putting into service,”
Article 14, paragraphs four and five:
“(4) Distributors that consider or have reason to believe that a device which they have made available on the market is not in conformity with this Regulation shall immediately inform the manufacturer and, where applicable, the authorized representative and the importer. Distributors shall cooperate with the manufacturer, where applicable the authorized representative, the importer and the Agency to ensure that the necessary corrective action to bring that device into conformity, to withdraw it or to recall it is taken. Where the distributor considers or has reason to believe that the device presents a serious risk, it shall also immediately inform the Agency, giving details, in particular, of the non-compliance and of any corrective action taken.”
“(5) Distributors that receive complaints or reports from healthcare professionals, patients or users about suspected adverse events related to a device which they have made available on the market shall immediately forward this information to the manufacturer and, where applicable, the authorized representative and the importer. Distributors shall keep a register of complaints, of non-conforming devices and of recalls and withdrawals, shall keep the manufacturer and, where available, the authorized representative and the importer informed of such monitoring and shall provide them, upon their request, with any information.”
Article 25 regulates identification within the supply chain:
“(2) Economic operators shall be able to identify the following to the Agency and, where the device is made available on the EU market, to the competent authorities of the relevant EU Member States, for the period referred to in the eighth paragraph of Article 10:”
“(a) any economic operator to whom they have directly supplied a device,”
“(b) any economic operator who has directly supplied them with a device,”
“(c) any health institution or healthcare professional to which they have directly supplied a device.”
The period in the referenced Article 10/8-a:
“(a) keep the technical documentation, the EU declaration of conformity and, if applicable, a copy of any relevant certificate issued in accordance with Article 56, including any amendments and supplements, available for a period of at least 10 years after the last device covered by the EU declaration of conformity has been placed on the market, and present them to the Agency upon request. For implantable devices, this period is at least 15 years after the last device has been placed on the market.”
For the other obligations of distributors and importers, see our articles on importer and distributor obligations, and for traceability, supply chain traceability.
8. Withdrawal and Destruction Notifications in ÜTS
Article 18 of the ÜTS Tekil Hareket Bildirimleri Kılavuzu (ÜTS Individual Movement Notifications Guide) regulates the movement of products for which a withdrawal decision has been made:
“(1) A withdrawal decision is made for a product whose use is found unsuitable by TİTCK or by the manufacturer/importer that placed the product on the market. The movement of individual products for which a withdrawal decision has been made, to the relevant institutions to be subjected to corrective action or not to be placed on the market again, is made only with the “Geri Çekme Verme Bildirimi” (Withdrawal Giving Notification).”
“(2) A giving notification cannot be used for individual products subject to a withdrawal decision.”
Under Article 19 of the Guide, products given with a withdrawal giving notification are accepted with a “Geri Çekme Alma Bildirimi” (Withdrawal Receiving Notification), and a new manufacture/import notification cannot be made for the lot number for which a withdrawal decision has been made. For products that endanger health, Article 21:
“(1) Where products that would endanger the health of patients and users when used are identified, a “İmha/Bertaraf Bildirimi” (Destruction/Disposal Notification) is made to remove these individual products from the system.”
Under Article 9 of the Guide, information that will facilitate tracking, such as an invoice number, waybill number or record, can be entered in the mandatory “Belge Numarası” (Document Number) field of the giving notification. For all of the notifications, see our article on ÜTS individual movement notifications, and for the service, see our page on the ÜTS individual notification service.
9. Frequently Asked Questions
How long does a sales center keep supply chain records?
Under Article 31/3 of the Regulation, it keeps them for at least ten years from the date it begins to make the device available on the market and submits them to the Agency upon request.
Which documents does the five-year retention period cover?
Under Article 8/6, documents relating to the activities carried out by the sales center under this Regulation are retained for five years.
Whom is an adverse event reported to?
Under Article 31/1, it is reported immediately to the Agency and to the manufacturer or importer of the device concerned. This obligation applies to its own devices and to other devices.
What is done if the Agency announces an unsafe device?
Under Article 31/2, the sale is stopped immediately, the devices are returned to the manufacturer or importer, and information and documents are shared with the Agency upon request. Under Article 29, a violation is a ground for fifteen days of suspension of activity.
Who is responsible for the accuracy of the information entered into ÜTS?
Under Article 31/4, the accuracy of the information on the devices registered in the system is the responsibility of the sales center that makes the product registration.
ÜTS registration and individual notification services for your sales center: Medical Device ÜTS Registration Consultancy
Sources



